Abstract:<p>Quercetin is the major representative of the flavonoid subgroup of flavones, with good pharmacological activities for the treatment of liver diseases, including liver steatosis, fatty hepatitis, liver fibrosis, and liver cancer. It can significantly influence the development of liver diseases via multiple targets and multiple pathways via antifat accumulation, anti-inflammatory, and antioxidant activity, as well as the inhibition of cellular apoptosis and proliferation. Despite extensive research on understanding the mechanism of quercetin in the treatment of liver diseases, there are still no targeted therapies available. Thus, we have comprehensively searched and summarized the different targets of quercetin in different stages of liver diseases and concluded that quercetin inhibited inflammation of the liver mainly through NF-κB/TLR/NLRP3, reduced PI3K/Nrf2-mediated oxidative stress, mTOR activation in autophagy, and inhibited the expression of apoptotic factors associated with the development of liver diseases. In addition, quercetin showed different mechanisms of action at different stages of liver diseases, including the regulation of PPAR, UCP, and PLIN2-related factors via brown fat activation in liver steatosis. The compound inhibited stromal ECM deposition at the liver fibrosis stage, affecting TGF1β, endoplasmic reticulum stress (ERs), and apoptosis. While at the final liver cancer stage, inhibiting cancer cell proliferation and spread via the hTERT, MEK1/ERK1/2, Notch, and Wnt/β-catenin-related signaling pathways. In conclusion, quercetin is an effective liver protectant. We hope to explore the pathogenesis of quercetin in different stages of liver diseases through the review, so as to provide more accurate targets and theoretical basis for further research of quercetin in the treatment of liver diseases.</p>

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the protective effects and molecular mechanisms of quercetin in different stages of liver disease. Specifically, the paper aims to provide a more precise target and theoretical basis for further research on the application of quercetin in the treatment of liver diseases by comprehensively reviewing and summarizing the multi-target and multi-pathway effects of quercetin in the treatment of hepatic steatosis, steatohepatitis, liver fibrosis, and liver cancer. ### Main Issues: 1. **Hepatic Steatosis**: How quercetin reduces fat accumulation by promoting fat browning and regulating lipid autophagy. 2. **Steatohepatitis**: How quercetin alleviates liver damage by inhibiting oxidative stress and inflammatory responses. 3. **Liver Fibrosis**: How quercetin slows the progression of liver fibrosis by inhibiting extracellular matrix deposition and endoplasmic reticulum stress. 4. **Liver Cancer**: How quercetin exerts anti-cancer effects by inhibiting the proliferation and spread of cancer cells. ### Specific Objectives: - **Explore the mechanisms of quercetin in different stages of liver disease**: By summarizing existing research, reveal the specific molecular targets and signaling pathways of quercetin at different pathological stages. - **Provide a theoretical basis**: Provide scientific evidence and potential therapeutic targets for future research on the application of quercetin in the treatment of liver diseases. ### Key Findings: - **AMPK Pathway**: Quercetin reduces fat accumulation by promoting fat browning and lipid autophagy through the activation of the AMPK pathway. - **UCP and PPAR Pathways**: Quercetin improves energy metabolism and lipid metabolism by regulating the expression of UCP and PPAR. - **Antioxidant and Anti-inflammatory Effects**: Quercetin reduces oxidative stress and inflammatory responses by inhibiting the NF-κB/TLR/NLRP3 pathway. - **Apoptosis-related Factors**: Quercetin reduces cell apoptosis by regulating apoptosis-related factors such as Bax and Bcl-2. Through these studies, the paper hopes to provide new ideas and scientific evidence for the development of more effective treatments for liver diseases.

Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanism

A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms

Quercetin and non-alcoholic fatty liver disease: A review based on experimental data and bioinformatic analysis

Mechanism of Action of Dihydroquercetin in the Prevention and Therapy of Experimental Liver Injury

Quercetin alleviates liver fibrosis via regulating glycolysis of liver sinusoidal endothelial cells and neutrophil infiltration

Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies

The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice

The role of quercetin in the treatment of liver diseases: the review based on experimental and clinical investigations

Quercetin Attenuates the Activation of Hepatic Stellate Cells and Liver Fibrosis in Mice Through Modulation of HMGB1-TLR2/4-NF-κB Signaling Pathways.

Novel insights into the role of quercetin and kaempferol from Carthamus tinctorius L. in the management of nonalcoholic fatty liver disease via NR1H4-mediated pathways

Quercitrin Attenuates Acetaminophen-Induced Acute Liver Injury by Maintaining Mitochondrial Complex I Activity

A systematic review on hepatoprotective activity of quercetin against various drugs and toxic agents: Evidence from preclinical studies

Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy

Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation

Quercetin mitigates ethanol-induced hepatic steatosis in zebrafish via P2X7R-mediated PI3K/ Keap1/Nrf2 signaling pathway

Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements

Integrated network pharmacology, metabolomics and molecular docking analysis to reveal the mechanisms of quercetin in the treatment of hyperlipidemia

Quercetin Promotes the M1-to-M2 Macrophage Phenotypic Switch During Liver Fibrosis Treatment by Modulating the JAK2/STAT3 Signaling Pathway

Quercetin attenuates high fructose feeding-induced atherosclerosis by suppressing inflammation and apoptosis via ROS-regulated PI3K/AKT signaling pathway

Quercetin ameliorates hepatic fat accumulation in high-fat diet-induced obese mice via PPARs

Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice